Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer.

Serum miR-210 Contributes to Tumor Detection, Stage Prediction and Dynamic Surveillance in Patients with Bladder Cancer.

MiR-210 is the master hypoxamir that generally exhibits oncogenic properties in most human solid tumors including bladder cancer (BC). However, it remains unknown about the clinical significance of circulating miR-210 levels in BC. In this study, we found that serum miR-210 was up-regulated in patie...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Yongmei Yang, Ailin Qu, Jingkang Liu, Rui Wang, Yingjie Liu, Gang Li, Weili Duan, Qian Fang, Xiumei Jiang, Lili Wang, Guixi Zheng, Lutao Du, Xin Zhang, Chuanxin Wang
Aineistotyyppi: Artikkeli
Kieli:English
Julkaistu: Public Library of Science (PLoS) 2015-01-01
Sarja:PLoS ONE
Linkit:http://europepmc.org/articles/PMC4529273?pdf=render

Internet

http://europepmc.org/articles/PMC4529273?pdf=render

Samankaltaisia teoksia